Document Detail


The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer.
MedLine Citation:
PMID:  3675190     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We evaluate the prognostic significance of preoperative natural killer (NK) cytotoxicity for K562 cells and its relationship to other prognostic factors in 102 patients with colorectal cancer who underwent curative resections between February 1984 and February 1985. The 18 patients who had recurrences within two years of surgery had significantly higher numbers of preoperative peripheral blood suppressor/cytotoxic and NK cells and significantly lower preoperative NK cytotoxicity than disease-free patients. Low preoperative NK cytotoxicity was predictive of recurrence independent of age, sex, hematocrit, procedure, blood loss, duration of surgery, Dukes' stage, specimen length, tumor size, tumor differentiation, and post-operative therapy. Low levels of in vitro NK-cell cytotoxicity may identify a subgroup of patients at high risk for recurrence.
Authors:
P I Tartter; B Steinberg; D M Barron; G Martinelli
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Archives of surgery (Chicago, Ill. : 1960)     Volume:  122     ISSN:  0004-0010     ISO Abbreviation:  Arch Surg     Publication Date:  1987 Nov 
Date Detail:
Created Date:  1987-11-27     Completed Date:  1987-11-27     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9716528     Medline TA:  Arch Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1264-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Mount Sinai Medical Center, New York, NY 10029.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Colonic Neoplasms / immunology*,  surgery
Cytotoxicity, Immunologic
Female
Humans
Killer Cells, Natural / immunology*
Male
Neoplasm Recurrence, Local
Prognosis
Rectal Neoplasms / immunology*,  surgery
Grant Support
ID/Acronym/Agency:
1 R01-CA-35558-01/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous...
Next Document:  Enhancement of tumor blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in ...